Speakers

Dr. Patrick Ahlers, PhD

Deputy Head of Development - Teamleader Scientists

Corden Pharma International GmbH

Fernando Albericio, PhD

Research Professor, School of Chemistry

University of Kwazulu-Natal

Julia Alterman, Ph.D.

Assistant Professor, RNA Therapeutics Institute

University of Massachusetts Chan Medical

Daniel Bachmann, PhD

Business Development Manager

Bachem AG

Victor Beaumont, PhD

Strategic Market Development Specialist

Bruker UK Limited

Christian Becker, Ph.D.

Professor and Head of the Institute of Biological

University of Vienna

Ralph Beneke

Market specialist molecular biology research

Agilent Technologies

Riccardo Bernasconi, Ph.D.

Director Business Development

Bachem

Lucas Bethge, Ph.D.

VP, Group Leader Chemistry

Silence Therapeutics

Dr. Nikita Brodyagin, PhD

Senior Scientist

Tessera Therapeutics

Tracey Burr, Ph.D.

Executive Director, CMC Regulatory Affairs

Ionis Pharmaceuticals

Dr James Button

Associate Principal Scientist

AstraZeneca

Dr. Walter Cabri, PhD

Full Professor of Organic Chemistry

University of Bologna

Judy Carmody, Ph.D.

Founder and Principal Consultant

Carmody Quality Solutions, LLC

Simone Carneiro, Ph.D.

Postdoctoral Fellow

LMU Munich

Melanie Cerullo

Cheif Quality & Regulatory Officer

ReciBioPharm

Osama Chahrour, PhD

Principal Scientist, Chemical Development

AstraZeneca

Jing Chen, Ph.D.

Director of Discovery DMPK

Arrowhead Pharmaceuticals

Kangming Chen, PhD

Head of mRNA & Plasmid Department

GenScript

Chris Chorley

Associate Director, Global Regulatory CMC, ASO Early Development Lead

Biogen

Ms. Meri Cizmar

Teamlead GMP Production

LGC Axolabs Berlin GmbH

Sophie Corbet

EMEA Bioprocessing Technical Service Manager

DuPont

David Craik, PhD

Professor of Biomolecular Structure

University of Queensland

Hagen Cramer, PhD

Chief Technology Officer

QurAlis

Stanley Crooke, MD, PhD

Founder and CEO

n-lorem Foundation

Beatriz De La Torre, Ph.D.

Research Professor, Laboratory of Medicine and Med

University Of KwaZulu-Natal

Anthony Ehkirch, Ph.D.

Principal Scientist and Analytical Expert

Novartis

Tomaz Einfalt, PhD

Principal Investigator II xRNA

Novartis Institutes for BioMedical Research

Patrick Endres

Manager – Product Management EMEA

Tosoh Bioscience GmbH

William Fang

Vice President of Oligonucleotide and Peptide Development

WuXi TIDES

Dr. Lucia Ferrazzano, PhD

Junior Assistant Professor

University of Bologna

Yannick Fillon, PhD

Head of Oligonucleotide Process Chemistry

Biogen

Dr. Daniela Fischer, Ph.D.

Associate Director Regulatory Affairs CMC

Novartis Pharmaceutical Manufacturing

Mr. Jonathan Fox

Consulting Scientist

Waters Corporation

Ashish Garg, Ph.D.

Director, Drug Product Development

Eli Lilly and Company

Derek Gauntlett

Director, Process Chemistry, Nucleic Acid Development & Manufacturing

Codexis

Xavier Gerard, Ph.D.

Field Application Scientist, EMEA

Thermo Fisher Scientific

Youme Gim

Team Leader, Oligonucleotide CDMO I

ST Pharm

Amanda Haas

Business Development Manager, Gene Editing Therapeutics

Agilent Technologies

Alastair Hay, Ph.D.

Vice President, Peptides

Almac

Christian Heinis, PhD

Associate Professor

Ecole PolyTechnique Federale de Lausanne

Dr. Christian Heinlein

Group Leader Bioanalytics at Axolabs GmbH

Axolabs GmbH

Søren Hough, PhD

Editor, Drug Modalities

Tides Global

Vusala Ibrahimova, Ph.D.

Research Scientist

CureVac SE

Frank Jaschinski, PhD.

Chief Scientific Officer

Secarna Pharmaceuticals

Mr. Jan Kehrbaum

Development Scientist

Novo Nordisk A/S

Michael Keller, PhD

Expert Scientist

F. Hoffmann - La Roche Ltd.

Jörg Kittelmann, Ph.D.

Principal Scientist, CMC Downstream API Development

Novo Nordisk

Bart Klein

Senior VP of Axiomer Technology

ProQR Therapeutics

Alexander Kleinsmann, PhD

Director R&D, CMC Development

Bachem AG

Laurent Knerr, Ph.D.

Principal Scientist

AstraZeneca

Troels Koch, PhD

Chief Technology Officer

MiNa Therapeutics

Dr. Anna Koijen, PhD

Principal Scientist

EnzyTag B.V.

Erich Koller, Ph.D.

Senior Principal Scientist

Roche Innovation Center Basel

Tom Krebstakies, PhD

Sales Manager - Europe & Asia

Asahi Kasei Bioprocess

Christoph Kroener, Ph.D.

Senior Director CMC IVAC Portfolio

BioNTech SE

Jesper Lau, PhD

Vice President, Digital Science & Innovation

Novo Nordisk A/S

Charlotte LeKieffre, PhD

Biopharma Application Specialist

Agilent Technologies

Jiazhen Liang, PhD

Senior Scientist

GenScript

Lennart Lindfors, Ph.D.

Senior Principal Scientist, Pharmaceutical Science

AstraZeneca

Peter Lischka

Senior Director Virology / Head Translational Science

AiCuris Anti-infective Cures AG

Rocky Liu

International Business Director

Wuhu Huaren

Beatriz Llamusi, PhD

Chief Executive Officer & Co Founder

Arthex Biotech S.L.

Stephen Lock, PhD

Senior Market Development Manager

SCIEX

Olivier Ludemann-Hombourger, PhD

Director, Global Innovation and Technology

PolyPeptide Group

Morten Lundh, Ph.D.

Director, Drug Discovery Innovation

Gubra A/S

Leila Malik, PhD

CMC Project Director

Novo Nordisk

Joan Malmstrøm, Ph.D.

Principal Scientist, CMC Analytical Support

Novo Nordisk A/S

Aram Mangasarian, Ph.D.

Chief Executive Officer

TME Pharma

Dr. Heiko Manninga

CEO

Manninga Consulting

Jody Mason, PhD

Professor of Biochemistry

University of Bath

Patrizio Mattei, PhD

Expert Scientist, Medicinal Chemistry

F. Hoffmann-La Roche Ltd.

Sonja Merkas, Ph.D.

Founder

Livinovea

Dr. Mathew Miller, PhD

Director, Life Science and RNA Technologies

Codexis

Dr. Alejandro Montaner

CEO

Immunalgia Therapeutics

Bruce Morimoto, PhD

Vice President, Drug Development

Alto Neuroscience

Jale Muslehiddinoglu, PhD

Vice President of Strategic Innovation

ST Pharm

Dr. Ganesh Nawale, PhD

Senior Scientist, Oligonucleotides

Cytiva

Peter Nielsen, PhD

Professor

University of Copenhagen

Dr. Takumi Okuda, PhD

Postdoc, Laboratory of Claudia Höbartner

University of Würzburg

Sheena Ong, PhD

Scientist

Biosynth

Rachel Orr

Director of CMC Data Transformation Delivery

GSK

Chris Oswald

Founder, Owner, and Principal Consultant

Coswald Consulting LLC

Jan Pawlas, PhD

Scientist

PolyPeptide Group

Trine Puggaard Petersen, PhD

Specialist, CMC API Chemical Development

Novo Nordisk

Barbara Pfaff, PhD

QC Manager Molecular Sequencing

BioSpring GmbH

Thi Lan Phuong Pham

Project Lead GMP and Large Scale Production

BioSpring GmbH

Daniel Pinchuk, PhD

Oligonucleotide Team Leader, Chemical R&D

Teva

Dr. Elias Post, PhD

Senior Scientist

Synaffix/Lonza

Leo Qian, PhD

Co-Founder and Vice President, Discovery Research

Entrada Therapeutics

Dr. Jyothi Rangineni, PhD

Senior Process Scientist

Fluid Air

Thomas Rupp

Managing Director

Axolabs Berlin GmbH

Yogesh Sanghvi, PhD

President

Rasayan Inc.

Gajan Santhakumar, Ph.D.

Associate Principal Scientist, Early Chemical Development

AstraZeneca

Dr. Christina Schroeder, Ph.D.

Senior Fellow, Peptide Therapeutics

Genentech

Andrea Schuster

Senior Scientist

Axolabs GmbH

Dr. Ronak Shah, PhD

Director

Beam Therapeutics

Filippo Sladojevich, Ph.D.

Senior Principal Scientist

Hoffmann-La Roche

Dan Stanton

Editorial Director

Informa Connect Life Sciences

Steven Stanton

Senior Scientist in Oligonucleotide Process Chemistry

AstraZeneca

Bryan Stroup

Senior Validation Scientist, Process Development

Nitto Denko Avecia

Daisuke Takahashi, PhD

Executive Specialist

Ajinomoto Co. Inc.

George Thom

Director, mRNA Team Leader

AstraZeneca

Karina Thorn, PhD

Corporate VP and Head of Research, Global Nucleic Acid Therapies (GNAT)

Novo Nordisk

Jyothi Thundimadathil, Ph.D.

Director of Drug Substance Development CMC

Carmot Therapeutics

René Thürmer, PhD

Deputy Head

BfArM Federal Institute for Drugs & Medical Devices

Michael Tikhonov

Analytical Group Manager, Oligonucleotides and Peptides

Teva

Sergey Tsukanov, Ph.D.

Senior Director Chemistry

Eli Lilly and Company

Eric van der Veer, PhD

Chief Innovation Officer

Hybridize Therapeutics

Dr. Janika Viereck, PhD

Head of R&D

Cardior Pharmaceuticals GmbH - a Novo Nordisk company

Letizia Volpe, Ph.D.

Site MS&T Head Chemical Operations

Novartis

Antti Vuolanto

Chief Executive Officer

Herantis Pharma plc

Dr. Zhong Wang, PhD

Founder & CTO

Allbiosyn Biotechnology Co., Ltd.

Zi Jun Emma Wang, PhD

Chief Technology Officer

YolTech Therapeutics

Daniel Waschke, Ph.D.

Technical Regulatory Manager

F. Hoffmann-La Roche Ltd.

Mike Webb, Ph.D.

Founder and CEO

Mike Webb Pharma

Dr. Tsuyoshi Yamamoto, PhD

CSO

Liid Pharmaceuticals

Yi Yang, PhD

Lead Scientist

Ferring Pharmaceuticals A/S